Clinical Cancer Research Prevention Award Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lloyd, J. M.
Right arrow Articles by Hardingham, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lloyd, J. M.
Right arrow Articles by Hardingham, J. E.
Clinical Cancer Research Vol. 12, 417-423, January 2006
© 2006 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

Identification of Early-Stage Colorectal Cancer Patients at Risk of Relapse Post-Resection by Immunobead Reverse Transcription-PCR Analysis of Peritoneal Lavage Fluid for Malignant Cells

Julia M. Lloyd1,2, Cassandra M. McIver1,3, Sally-Anne Stephenson1, Peter J. Hewett2, Nicholas Rieger2 and Jennifer E. Hardingham1,3

Authors' Affiliations: Departments of 1 Haematology-Oncology and 2 Surgery, The Queen Elizabeth Hospital, Woodville, South Australia, Australia and 3 Department of Physiology, Adelaide University, Adelaide, South Australia, Australia

Requests for reprints: Jennifer E. Hardingham, Department of Haematology-Oncology, Basil Hetzel Institute, The Queen Elizabeth Hospital, 28 Woodville Road, Woodville, Australia 5011. Phone: 61-8-82226142; Fax: 61-8-82226144; E-mail: jenny.hardingham{at}nwahs.sa.gov.au.

Purpose: Colorectal cancer patients diagnosed with stage I or II disease are not routinely offered adjuvant chemotherapy following resection of the primary tumor. However, up to 10% of stage I and 30% of stage II patients relapse within 5 years of surgery from recurrent or metastatic disease. The aim of this study was to determine if tumor-associated markers could detect disseminated malignant cells and so identify a subgroup of patients with early-stage colorectal cancer that were at risk of relapse.

Experimental Design: We recruited consecutive patients undergoing curative resection for early-stage colorectal cancer. Immunobead reverse transcription-PCR of five tumor-associated markers (carcinoembryonic antigen, laminin {gamma}2, ephrin B4, matrilysin, and cytokeratin 20) was used to detect the presence of colon tumor cells in peripheral blood and within the peritoneal cavity of colon cancer patients perioperatively. Clinicopathologic variables were tested for their effect on survival outcomes in univariate analyses using the Kaplan-Meier method. A multivariate Cox proportional hazards regression analysis was done to determine whether detection of tumor cells was an independent prognostic marker for disease relapse.

Results: Overall, 41 of 125 (32.8%) early-stage patients were positive for disseminated tumor cells. Patients who were marker positive for disseminated cells in post-resection lavage samples showed a significantly poorer prognosis (hazard ratio, 6.2; 95% confidence interval, 1.9-19.6; P = 0.002), and this was independent of other risk factors.

Conclusion: The markers used in this study identified a subgroup of early-stage patients at increased risk of relapse post-resection for primary colorectal cancer. This method may be considered as a new diagnostic tool to improve the staging and management of colorectal cancer.




This article has been cited by other articles:


Home page
Anticancer ResHome page
T. TOYOSHIMA, E. VAIRAKTARIS, E. NKENKE, K. A. SCHLEGEL, F. W. NEUKAM, and J. RIES
Hematogenous Cytokeratin 20 mRNA Detection Has Prognostic Impact in Oral Squamous Cell Carcinoma: Preliminary Results
Anticancer Res, January 1, 2009; 29(1): 291 - 297.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. Takagawa, S. Fujii, M. Ohta, Y. Nagano, C. Kunisaki, S. Yamagishi, S. Osada, Y. Ichikawa, and H. Shimada
Preoperative Serum Carcinoembryonic Antigen Level as a Predictive Factor of Recurrence After Curative Resection of Colorectal Cancer
Ann. Surg. Oncol., December 1, 2008; 15(12): 3433 - 3439.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
C. Shen, L. Hu, L. Xia, and Y. Li
Quantitative Real-time RT-PCR Detection for Survivin, CK20 and CEA in Peripheral Blood of Colorectal Cancer Patients
Jpn. J. Clin. Oncol., November 1, 2008; 38(11): 770 - 776.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. Rekhraj, O. Aziz, S. Prabhudesai, E. Zacharakis, F. Mohr, T. Athanasiou, A. Darzi, and P. Ziprin
Can intra-operative intraperitoneal free cancer cell detection techniques identify patients at higher recurrence risk following curative colorectal cancer resection: a meta-analysis
Ann. Surg. Oncol., January 1, 2008; 15(1): 60 - 68.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.